Litigation Details for Egalet US, Inc. v. Teva Pharmaceuticals USA, Inc. (D. Del. 2018)
✉ Email this page to a colleague
Egalet US, Inc. v. Teva Pharmaceuticals USA, Inc. (D. Del. 2018)
Docket | ⤷ Sign Up | Date Filed | 2018-04-04 |
Court | District Court, D. Delaware | Date Terminated | 2018-10-30 |
Cause | 35:271 Patent Infringement | Assigned To | Colm Felix Connolly |
Jury Demand | None | Referred To | |
Parties | TEVA PHARMACEUTICALS USA, INC. | ||
Patents | 9,044,402; 9,549,899 | ||
Attorneys | Johnathan D. Ball | ||
Firms | Morris, Nichols, Arsht & Tunnell | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in Egalet US, Inc. v. Teva Pharmaceuticals USA, Inc.
Details for Egalet US, Inc. v. Teva Pharmaceuticals USA, Inc. (D. Del. 2018)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
0000-00-00 | External link to document | |||
2018-07-23 | 18 | Stipulation of Dismissal | Dismissal Of Counterclaims Pertaining To U.S. Patent No. 9,549,899 by Teva Pharmaceuticals USA, Inc.. (Keller…2018 30 October 2018 1:18-cv-00505 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
2018-07-25 | 20 | SO ORDERED | Dismissal Of Counterclaims Pertaining To U.S. Patent No. 9,549,899 filed by Teva Pharmaceuticals USA, Inc..…2018 30 October 2018 1:18-cv-00505 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document |
2018-10-30 | 31 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,044,402 B2. (Attachments: #…2018 30 October 2018 1:18-cv-00505 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document | |
2018-04-04 | 4 | the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,044,402 B2. (rwc) (Entered:…2018 30 October 2018 1:18-cv-00505 835 Patent - Abbreviated New Drug Application(ANDA) None | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |